ArticleCureus2026
Diagnostic Accuracy of the Patra Index and Red Cell Distribution Width Index in Distinguishing Beta-Thalassemia Trait From Iron Deficiency Anemia: A Retrospective Comparative Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Distinguishing beta-thalassemia trait (BTT) from iron deficiency anemia (IDA) remains a clinical challenge, particularly in resource-limited settings where nutritional anemia is highly prevalent. This study aimed to compare the diagnostic accuracy of the Patra index with the red cell distribution width index (RDWI) for differentiating BTT from IDA, using high-performance liquid chromatography (HPLC) and serum ferritin as reference standards. Methods This retrospective diagnostic accuracy study was conducted at Rajendra Institute of Medical Sciences, Ranchi, India. A total of 156 patients diagnosed with either BTT or IDA were included. BTT was defined as hemoglobin A2 (HbA2) > 3.5%, and IDA as serum ferritin < 15 ng/mL with HbA2 < 3.5%. The Patra index was calculated as mean corpuscular volume divided by red cell distribution width (MCV/RDW), with a cutoff of ≥5.3 for BTT. RDWI was calculated with a cutoff of <220 for BTT. Diagnostic performance metrics, including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and 95% confidence intervals (CIs), were determined. Receiver operating characteristic (ROC) curve analysis was performed to assess overall discriminative ability. Results Of the 156 patients, 53 (33.97%) had BTT and 103 (66.03%) had IDA. At the predefined cutoff, the Patra index demonstrated a sensitivity of 83.02% (95% CI: 70.2%-91.9%) and a specificity of 100.0% (95% CI: 96.5%-100.0%), yielding a diagnostic accuracy of 94.23%. In comparison, RDWI showed a sensitivity of 100.0% (95% CI: 93.3%-100.0%) and a specificity of 81.55% (95% CI: 72.7%-88.5%), with a diagnostic accuracy of 87.82%. The area under the ROC curve for the Patra index was 0.989. Conclusion In this study population, the Patra index exhibited high specificity for differentiating biochemically confirmed BTT from IDA, although its moderate sensitivity limits its utility as a standalone screening tool. It may serve as a simple, cost-effective adjunct or triage tool in resource-limited settings, with confirmatory biochemical testing remaining essential for definitive diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.